Natick medical device maker Boston Scientific Corp. said today that it has begun marketing a new catheter that is designed for use in patients undergoing peripheral angioplasty procedures below the knee.
The small size and maneuverability of the Coyote Balloon Catheter make it well suited for treating blood vessels in the body’s lower extremities, the company’s press release noted. Boston Scientific said it has begun marketing the product in the United States and in Europe as well as in other international markets.
With about $7.8 billion in 2010 sales, Boston Scientific is perhaps best known for medical devices such as stents and defibrillators, which are used in the treatment of patients with heart ailments. The company also has a catheter business. Balloon catheters are used to open blocked arteries.
Last week, Boston Scientific announced that Michael Mahoney, an executive at rival stent maker Johnson & Johnson, will become its chief executive in November 2012.
Mahoney will become Boston Scientific president next month, and he is scheduled to assume the chief executive’s role after his post-employment obligations end as worldwide chairman of the medical device and diagnostics group for Johnson & Johnson.
Earlier this year, J. Raymond Elliott announced that he would step down as Boston Scientific’s president and chief executive.